Mirabegron and B-lymphocyte abnormalities - a phase IV clinical study of FDA data

Summary:

B-lymphocyte abnormalities is reported as a side effect among people who take Mirabegron (mirabegron), especially for people who are female, 40-49 old, also take Ocrevus, and have Primary progressive multiple sclerosis.

The phase IV clinical study analyzes which people have B-lymphocyte abnormalities when taking Mirabegron. It is created by eHealthMe based on reports of 5,378 people who have side effects when taking Mirabegron from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is B-lymphocyte abnormalities?

B-lymphocyte abnormalities (abnormal population of b lymphocytes in the blood, bone marrow, or tissues) is found to be associated with 22 drugs and 43 conditions by eHealthMe. Check the latest studies of B-lymphocyte abnormalities.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,378 people reported to have side effects when taking Mirabegron.
Among them, 17 people (0.32%) have B-lymphocyte abnormalities.

Could Mirabegron cause B-lymphocyte abnormalities?

Among these 17 people:

What is the gender of people who have B-lymphocyte abnormalities when taking Mirabegron? *

female: 100 %
male: 0.0 %

What is the age of people who have B-lymphocyte abnormalities when taking Mirabegron? *

What are other drugs people take besides Mirabegron? *

Ocrevus: 17 people, 100.00%
Trospium Chloride: 16 people, 94.12%
Levothyroxine Sodium: 16 people, 94.12%
Escitalopram: 16 people, 94.12%
Acyclovir: 16 people, 94.12%
Promethazine Hydrochloride: 6 people, 35.29%
Zanaflex: 1 person, 5.88%
Vitamin D3: 1 person, 5.88%
Proventil: 1 person, 5.88%
Lisinopril: 1 person, 5.88%

What are other side effects people have besides B-lymphocyte abnormalities? *

Vulvovaginitis (inflammation of the vulva and vagina): 16 people, 94.12%
Hypoaesthesia (reduced sense of touch or sensation): 16 people, 94.12%
Burning Sensation: 16 people, 94.12%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 16 people, 94.12%
Dry Skin: 16 people, 94.12%
Fatigue (feeling of tiredness): 16 people, 94.12%
Genital Herpes (herpes infection of genital): 16 people, 94.12%
Genital Tract Inflammation: 16 people, 94.12%
Hair Loss: 16 people, 94.12%
Hot Flush (sudden feelings of heat): 16 people, 94.12%

What are the existing conditions these people have? *

Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 17 people, 100.00%
Wound: 16 people, 94.12%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 88.24%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and have B-lymphocyte abnormalities?

- Check whether B-lymphocyte abnormalities is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirabegron:

Mirabegron (5,414 reports)

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with B-lymphocyte abnormalities:

B-lymphocyte abnormalities (22 drugs)

Browse all the conditions that are associated with B-lymphocyte abnormalities:

B-lymphocyte abnormalities (43 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Mirabegron) and Mirabegron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.